Biotech keeps rising as investors worry end is coming
Huge IPOs, valuations for firms that don't yet have a single drug for sale are driving boom
Sat, Mar 07, 2015 - 5:50 AM
HANDLE WITH CARE: There is concern that just a few failures in clinical trials could send investors fleeing the booming biotech industry.
BIOTECH'S days of unfettered optimism may be numbered. Since 2011, money has flowed almost non-stop into the industry as investors buy into the promise of new drugs. Signs are increasingly pointing towards an end to the boom.